Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Nicotinamide riboside (NR) is in wide use as an NAD + precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood NAD + metabolism in humans. We report that human blood NAD + can rise as much as 2.7-fold with a single oral dose of NR in a pilot study of one individual, and that oral NR elevates mouse hepatic NAD + with distinct and superior pharmacokinetics to those of nicotinic acid and nicotinamide. We further show that single doses of 100, 300 and 1,000 mg of NR produce dose-dependent increases in the blood NAD + metabolome in the first clinical trial of NR pharmacokinetics in humans. We also report that nicotinic acid adenine dinucleotide (NAAD), which was not thought to be en route for the conversion of NR to NAD + , is formed from NR and discover that the rise in NAAD is a highly sensitive biomarker of effective NAD + repletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NAM, in contrast, is a well reported and widely used sirtuin inhibitor31 and has been recently shown to inhibit NAD+-consuming activities in vivo24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In another study, NAAD was not detected in human blood prior to NR supplementation, while there was a ∼2,900% increase in NAAD baseline in healthy individuals taking single doses of up to 1 g NR (100, 300, and 1000 mg) [63].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“It is still unclear why NR administration increases NAD+ levels more than NAM and NA treatment [63], while NMN and NAM administration showed no difference in NAD levels in blood and liver [90].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, by LC-tandem MS and with the use of internal standards, the baseline concentrations of hepatic NMN and NAD+ were determined to be ∼2 and ∼1,000 pmol mg−1, respectively, rising to ∼10 and ∼4,000 pmol mg−1, respectively, 6 h after oral gavage of 185 mg kg−1 NR24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“This concept was established by a recent study in which orally administered equimolar NAM, NR and NA produced unique effects on hepatic NAD+ metabolism through distinct biosynthetic routes24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Braidy, N., Poljak, A., Grant, R., Jayasena, T., Mansour, H., Chan‐Ling, T., Guillemin, G. J., Smythe, G. A., & Sachdev, P. S. (2013) · Biogerontology · doi:10.1007/s10522-013-9489-5 · Cited by 126
RetractedDose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C.-X., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Research works printed but not linked: 1
- Altman, L. K. Who Goes First: The Story of Self-experimentation in Medicine University of California Press (1987).
Cited by
Items 601–696 of 696
Tie, H., Hou, M., Li, Y., Pan, M., Neumann, D., Liu, R., Zhang, J., Hoes, M. F., Nabben, M., Glatz, J. F. C., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.078376 · Cited by 4
Potential significance of NAD+ biology translational research in super-aged Japan
山口慎太郎, 裕, 伊., & 純, 吉. (2020) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.57.213 · Cited by 1
Canonical and novel strategies to delay or reverse aging
Gilmour, B. C., Bergersen, L. H., & Fang, E. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91617-2.00005-5 · Cited by 2
Braidy, N., & Sachdev, P. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823679-6.00005-9 · Cited by 1
NAD+– ein alter Bekannter aus den Anfängen der Orthomolekularen Medizin
Gröber, U. (2023) · Zeitschrift für Orthomolekulare Medizin · doi:10.1055/a-2200-2138 · Cited by 1
The adverse effects of oral niacin/nicotinamide - an overview of reviews
Young, S. L., & Gazzard, G. (2025) · Eye · doi:10.1038/s41433-025-04027-2 · Cited by 5
“…involving both healthy human volunteers and mice, an NR dose of 1000 mg twice daily (2000 mg in total) can significantly increase blood levels of NAD ∫∠ (up to 2.7 fold after one dose) and that single doses of 100, 300 and 1000 mg of NR produce dose-dependent increases in blood levels of NAD [32].”
InfluentialNAD+ controls circadian rhythmicity during cardiac aging
Carpenter, B. J., Lecacheur, M., Mangold, Y. N., Cui, K., Günther, S., Vermunt, M. W., & Dierickx, P. (2026) · Communications Biology · doi:10.1038/s42003-026-09818-1 · Cited by 5
“These findings are in line with previous results 4,28 and could be due to high cardiac metabolic turnover 29 .”
Cantó, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811752-1.00017-1 · Cited by 1
Nicotinamide Adenine Dinucleotide (NAD+) in Aging
Braidy, N., Poljak, A., & Sachdev, P. S. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_1035-1 · Cited by 1
Voth, L. S., O’Connor, J. J., Kerr, C. M., Doerger, E., Schwarting, N., Sperstad, P. D., Johnson, D. K., & Fehr, A. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.30.437796 · Cited by 1
“PARP inhibitors significantly enhance the replication of MHV D1329A, while boosting the PARP substrate NAD+ with nicotinamide riboside further inhibits D1329A replication The D1329 residue is known to be critical for ADP-ribose binding from multiple studies (28, 29), however it is also conceivable that this mutation c…”
BackgroundInfluentialConnell, N. J. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210122nc · Cited by 1
Igarashi, M., Miura, M., Nakagawa-Nagahama, Y., Yaku, K., Kashiwabara, K., Sawada, M., Sekine, R., Fukamizu, Y., Sato, T., Sakurai, T., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-455083/v1 · Cited by 1
Long-Term NMN Treatment Increases Lifespan and Healthspan in Mice in a Sex Dependent MannerPreprint
Kane, A. E., Chellappa, K., S, M., Arnold, M. W., Li, J., Amorim, J. A., Diener, C., Zhu, D., Mitchell, S. J., Griffin, P. T., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4857461 · Cited by 3
Saha, S., Meng, C., Dong, J., Zhou, J., Wang, S., Papaneri, A. B., Sun, L., Cai, H., & Cui, G. (2026) · Research Square · doi:10.21203/rs.3.rs-9970859/v1 · Cited by 1
Paalme, T., Vilbaste, A., Kevvai, K., Nisamedtinov, I., & Tanilas, K. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0592-3
Vitamin B3 salvage and NAD\(^+\) metabolism in skeletal muscle
Fletcher, R. S. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)
Katsyuba, E., & Auwerx, J. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813499-3.00003-4
Integrated Regulation of Cardiac Fatty Acid and Glucose Oxidation
Altamimi, T. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3028pv9d
mtDNA maintenance: disease and therapy
Quadalti, C., & Garone, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819656-4.00016-4
Novel nutraceuticals to tackle brain and muscle bioenergetics
Ostojić, S. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00019-x
Scope to develop sirtuins modulators as a therapy to attenuate cardiac complications
Bugga, P., & Banerjee, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814118-2.00018-5
The Role of NAD+ in Rejuvenating Human Body
Kiosk, B., & Biswas, S. (2020) · Biotechnology Kiosk · doi:10.37756/bk.20.2.12.1
“In this study, NAAD emerged as a sensitive biomarker [48].”
Background子宮内膜癌細胞株における抗癌剤感受性の検討(子宮体部悪性腫瘍VI, 第57回日本産科婦人科学会学術講演会)
茂木, 真., 新美, 茂., 高倉, 聡., 柳田, 聡., 岡本, 愛., 落合, 和., & 田中, 忠. (2005) · 日本産科婦人科學會雜誌
Skeletal muscle health in aging: a focus on mitochondria, metabolism and physical performance
Grevendonk, L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20211006lg
Nicotinamide Adenine Dinucleotide (NAD+) in Aging
Braidy, N., Poljak, A., & Sachdev, P. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_1035
Damschroder, D., Perez, R. Z., Houtkooper, R. H., & Wessells, R. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.06.475267
Imai, S. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726835440.793584719
Kane, A. E., & Sinclair, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62135-9
Morgan, B. P. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733535967.793564738
Preclinical safety assessments of nicotinamide riboside hydrogen malate
Dziwenka, M. M., & Mozingo, A. (2022) · Toxicology Research and Application · doi:10.1177/23978473221108881
“Other studies conducted with NR or NR containing test materials reported that NR exposure led to reduced weight gain or impacted body weight gain in preclinical studies.(2,4,11,27) In the current study, there were no adverse clinical signs reported and no change in the motor activity of the NRHM treated animals.”
ResultResolving Geroplasticity to the Balance of Rejuvenins and Geriatrins
TABIBZADEH, S. S. (2022) · Aging and Disease · doi:10.14336/ad.2022.0414
“Similarly, NR improves glucose tolerance, and in models of diabetes and high-fat diet, improves metabolic function, prevents obesity, and reduces fat deposition [455, 476-479].”
BackgroundSharing the load in NAD metabolism
Gazzaniga, F. S. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.11.011
Metabolic precursors of nicotinamide adenine dinucleotide and the potential for their clinical use
Sutsko, I. P., Shlyahtun, A. H., & Semenenya, I. N. (2022) · Medical academic journal · doi:10.17816/maj89964
Stan, T. L., Vijver, D. V. D., Verhaart, I. E. C., & Aartsma-Rus, A. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.02.526793
“These studies indicate NR is well-tolerated [38, 40-42] and can lead to increases blood NAD+ levels [43-46].”
From geroprotective tactics to anti-ageing strategy: ways to eliminate ageing per se
Baramiya, M. G., & Mykhalskiy, S. (2023) · Ageing & Longevity · doi:10.47855/jal9020-2023-2-2
Jahan, F., Vasam, G., Cariaco, Y., Nik-Akhtar, A., Green, A., Menzies, K. J., & Bainbridge, S. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.09.556974
“Moreover, NR has been shown to be orally bioavailable and safe for human consumption [27, 89-91].”
BackgroundLosung, F., Ginting, E. L., Abdjul, D. B., Kapojos, M. M., Maarisit, W., Mentang, F., Sumilat, D. A., Balansa, W., & Mangindaan, R. E. P. (2023) · Biodiversitas Journal of Biological Diversity · doi:10.13057/biodiv/d241212
Metabolism and Receptor Mechanisms of Niacin Action
Boronovskiy, S. E., Сергеевна, К. В., & Nartsissov, Y. R. (2023) · Tsitologiya · doi:10.31857/s0041377123060032
Biochemical Characterization and Inhibitor Discovery for Pf Sir2A – New Tricks for An Old EnzymePreprint
Donu, D., Boyle, E., Curry, A. M., & Cen, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.25.614941
Biochemical characterization and discovery of inhibitors for Pf Sir2A: new tricks for an old enzyme
Donu, D., Boyle, E., Curry, A. M., & Cen, Y. (2025) · RSC Chemical Biology · doi:10.1039/d4cb00206g
Mitochondrial Dysfunction: Potential Therapy For Abdominal Aortic Aneurysms
Yang, W., He, J., Yu, H., Wu, Y., & Shi, S. (2025) · Current Vascular Pharmacology · doi:10.2174/0115701611312293241220101556 · Cited by 2
The Application of Nicotinamide Coenzyme Precursors in Health Food
Feng, Z.-Y., She, J., Qin, Z., & Sheng, R. (2025) · Springer eBooks · doi:10.1007/978-981-97-9877-3_47
Leung, C. K.-S., Guo, P. Y., Mak, H. K., Weinreb, R. N., Chan, P. P., Yu, M., Yiu, K. F. C., Kam, K. W., Cowling, B. J., & Lai, G. W. K. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5233298
NAD+ metabolism as a target for anti-aging
Uchida, H., & Nakagawa, T. (2025) · Folia Pharmacologica Japonica · doi:10.1254/fpj.24072
Song, C., Li, Z., Zhao, L., Guo, Z. Y., Zhang, L., Hu, Y., Lei, Y., Han, Y., Xu, Y., Xiang, Z., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118792 · Cited by 1
Self-citationCifuentes, L. F., & Salzman, A. L. (2025) · International Journal of Nutrition and Food Sciences · doi:10.11648/j.ijnfs.20251404.12
Association Between Dietary Niacin Intake and Life's Essential 8 Among US Adults ( NHANES 2005–2018)
Wang, D., Yuan, F., & Hu, S.-L. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70817
“Experimental data have shown that NAD + - boosting strategies, including niacin supplementation, can influence key pathways related to lipid metabolism and inflammation (Katsyuba et al. 2020; Trammell et al. 2016).”
Zhang, Q., Yang, H. M., Yang, D., Lu, H., Xiong, M., Xie, L., Fan, Y., Zhang, K. F., Zhang, C., Ye, T., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1627679 · Cited by 2
“Its dual capacity to drive ATP production while maintaining redox balance provides comprehensive metabolic support for maturation-resistant oocytes (27).”
Khan, N. A., Ahlqvist, K. J., Pradhan, S., Landoni, J. C., Jackson, C. B., Zhaivoron, A., Kivelä, R., Euro, L., & Suomalainen, A. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117849 · Cited by 1
Caloric Restriction Mimetics and Their Neuroprotective Potential
Garg, G., Singh, I., Prabhu, P., & Jain, V. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2790-8_4
Wu, Z., Wan, Y., Liu, H., Liu, J., Hu, X., Meng, W., Yang, X., Pu, B., & Lin, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117585 · Cited by 1
Liao, B., Zhao, Y., Wang, D., Zhang, X., Hao, X., & Hu, M. (2021) · Figshare · doi:10.6084/m9.figshare.14936274
Song, M., Armenian, S. H., Bhandari, R., Lee, K., Ness, K. P. V., Putt, M., Lindenfeld, L., Manoukian, S., Wade, K., Dedio, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20342385
Esteban, M. Á., & Sánchez-Ferrer, Á. (2025) · Fishes · doi:10.3390/fishes10120647 · Cited by 1
“For instance, oral administration of NR enhances hepatic NAD + levels in mice more effectively than NA or NAM [26].”
Wang, H., Li, H., Liu, Y., Wang, X., He, C., Huang, J., Zhang, Y., Yang, Y., & Ge, N. N. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000866
“[7,8] NR has shown robust therapeutic benefits in ameliorating a variety of serious health conditions in humans, especially liver disease.”
Fischer, A. C., Georges, H. M., Jones, D. M., Chamley, L. W., & Abrahams, V. M. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70205
Çelik, A., Şahin, N., Orhan, C., Er, B., Erten, F., Ozmen, B., Tuzcu, M., Ozercan, I., & Şahin, K. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01153-7
Rizwan, U., Umar, S., Rizwan, U., Humza, A., & Uppal, M. R. (2026) · Annals of Clinical Endocrinology and Metabolism · doi:10.29328/journal.acem.1001032
Timing of NAD Deficiency During Organogenesis Dictates Defect Type and Penetrance
Bozon, K., Cuny, H., Sunn, N., Martin, E. M. M. A., Sheng, D. Z., Chapman, G., & Dunwoodie, S. L. (2026) · The FASEB Journal · doi:10.1096/fj.202502824rrr · Cited by 1
Zhao, Y., Ni, W., Yao, S., Yu, S., Wang, C., Jin, C., Wang, X., Feng, J., Cui, Y., Yu, X., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121376
Othman, M. B., & Sakamoto, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041912
“Recent research shows that increasing NAD+ levels through supplementation with precursors like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) can improve metabolic health, boost energy expenditure, and reduce fat accumulation in preclinical obesity models [20,21].”
Kitaoka, Y., Tsukahara, C., Fujita, N., Arizono, I., Otsubo, M., & Sase, K. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11607-2 · Cited by 1
Nicotinamide (Vitamin B3 ) Deficiency in Follicular Fluid of Patients With Ovarian Ageing
Bocca, C., Boguenet, M., Boucret, L., Bouet, P., Reynier, P., & May‐Panloup, P. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71085
Niacin Derivatives in MASLD: Metabolic and Therapeutic Insights
Rojo-López, M. I., Niño-Narvión, J., Antentas, M., Fernández‐Camins, B., Martínez-Rojo, E., Poca, M., Martínez‐Sánchez, M. A., Ramos‐Molina, B., Rossell, J., Mauricio, D., et al. (2026) · Nutrients · doi:10.3390/nu18060996
Cardoso, D. (2022) · theses.fr (ABES) · doi:10.70675/e5ce6d96z7253z4119zb119zc07f3977425d
López‐Blanch, R., Oriol‐Caballo, M., Palmer, R. S., Moreno-Murciano, P., Benlloch, M., Villaescusa, J. I., Montoro, A., Prohens, R., Albertí, J., Estrela, J. M., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119323 · Cited by 1
“…cocrystals (PTCC) and silybin-phosphatidylcholine (SILPC) [6,7], alongside nicotinamide riboside (NR, a vitamin B3 derivative and NAD ⁺ precursor) [8], and captopril (carboxyphenyl-thiazole, CPT, an angiotensin-converting enzyme inhibitor which has demonstrated radiomitigative effects across…”
Comprehensive metabolic programming by enzymatic nanovesicle for acute kidney injury therapy
Lei, Y., Wu, Y., Li, C., Zou, C., Mao, M., Zhuang, W., Qu, Y., He, J., Liang, C., Nie, W., et al. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.04.019
Nguyen, A. T., & Nguyen, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.07.716917
Alambarrio, D. A., Li, X., Zedonek, S. S., Willis, S. E., Proctor, J. N., Mozafari, F., Call, J. A., Delgado, L. E., Doran, M. S., & Gonzalez, J. M. (2026) · Metabolites · doi:10.3390/metabo16040261
“Specifically, NR is well tolerated at large clinical doses (up to 3000 mg/d), whereas painful skin flushing and sirtuin inhibition are associated with nicotinic acids and large-dose nicotinamide [17,18].”
Role of nicotinamide adenine dinucleotide in cardiovascular disease
Prasanna, J., Manickam, R., & Tipparaju, S. M. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001292
Nkrumah-Elie, Y. M., Kwon, J., Simpson, S., Idoine, R., Mavoyan, J. S., Russ, A., Cavanaugh, J., Hawkins, L., Fuller, K., Jaeger, J., et al. (2026) · medRxiv · doi:10.64898/2026.04.28.26352007 · Cited by 1
Meyer‐Ficca, M. L., & Chini, C. C. S. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100646
“Cow ’ s milk is rich in nicotinamide riboside (NR), another NAD precursor [4].”
De, A., Singh, A. K., & Ahmed, S. K. S. (2026) · Cosmoderma · doi:10.25259/csdm_6_2026
Warz, S.-I., Dierkes, J., Kaaks, R., Panico, S., Zamora-Ros, R., Nicolas, G., Sacerdota, C., Trobajo‐Sanmartín, C., Cabrera-Castro, N., Masala, G., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9436550/v1
The role of mitochondrial dynamics in metabolic dysfunction–associated steatotic liver disease
Yang, N., & Hao, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1804561 · Cited by 1
“A pilot study involving human participants ( n = 30) demonstrated that NR (500 mg/day) reduced liver fat fraction by 15% over a period of 12 weeks (53).”
Holmes, H. E., Srivastava, K., Scalici, J. M., Dhuguru, J., Shea, A. E., Migaud, M. E., & Dellinger, R. W. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1773667
“In addition, a single oral dose of NR at 100 mg, 300 mg or 1,000 mg demonstrated dose dependent increases in NAD+ metabolism in blood of healthy adults (Trammell et al., 2016).”
Self-citationSahin, K., & Erek, G. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261451345
Xu, X., Li, H., Li, J., & Huang, M. (2026) · The FASEB Journal · doi:10.1096/fj.202504570rr
Ghosh, A., Pranesh, G., Zachariah, N., Murakami, E., Heredia, A., Mathur, P., Burns‐Naas, L. A., WENG, S., Ramanathan, A., Kottilil, S., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1832979
“…NAD + precursors, including nicotinamide riboside and nicotinamide mononucleotide, which have demonstrated favorable safety profiles and dose-dependent increases in circulating NAD + levels (Trammell et al., 2016; Martens et al., 2018; Conze et al., 2019; Irie et al., 2020; Yoshino et al., 2021).”
Moshtaghion, S. M., Shayan, M., Ramakrishnan, S., Ham, A., Gharehkoshan, A. S., Morley, M. G., Zebardast, N., Diaz-Corrales, F. J. J., Rodríguez-de-la-Rúa-Franch, E., Husain, D., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1912337
“NR is well tolerated up to 2000 mg/day over 8–12 weeks and up to 3,000 mg/day in short-term safety trials, with only mild or transient adverse effects observed at higher doses (Berven et al., 2023; Martens et al., 2018; Trammell et al., 2016).”
Kołodziejska, R., Godlewski, A., Tafelska‐Kaczmarek, A., Kuk, J., Moritz, M., Sergot, K., Kurhaluk, N., Ткаченко, Г. М., & Woźniak, A. (2026) · Cells · doi:10.3390/cells15121103
“Oral NR administration elevates NAD + concentrations in humans (up to ~2.7-fold) and mice, with well-defined pharmacokinetics [158–160], and raises hep-atic NAD + more efficiently than nicotinic acid or NAM [160].”
InfluentialTranslational perspectives in drug discovery
Khamle, A. R., Kore, V. D., Lakhera, A., Panda, S. K., Bhalla, M., & Gupta, P. S. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45380-9.00013-4
Role of sirtuins in glucose and lipid metabolism
Swastik, V., & Kotnis, A. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45380-9.00003-1
The Tau-mitochondria connection and its impact on cellular energy metabolism in Alzheimer’s disease
Singh, A. K., Supraja, M. R., Amal, P. S., Krishnamoorthi, S., Iyaswamy, A., & Durairajan, S. S. K. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.06.002
Martens, C. R., Decker, K., DeConne, T. M., Sanjana, F., Horvat, F. M., Rizzi, N., Awad, C., Habash, E. M., Hobson, J. C., Kramer, M. K., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71605
Abanades, S., Fernández, I., Capdevila, N., & Burrull, F. C. (2026) · Nutrients · doi:10.3390/nu18162702
“NR has demonstrated oral bioavailability and the capacity to increase NAD + metabolism in humans [34]; however, disease-specific clinical evidence for NR or NMN in ME/CFS and fibromyalgia remains limited.”
Nicotinamide Mononucleotide Adenylyltransferase 1 and NAD+ Homeostasis in Neuroprotection and Aging
Sun, Y., Li, B., & Qian, Z. (2026) · Metabolites · doi:10.3390/metabo16080597 · Cited by 1
“NR enhances oxidative metabolism in mice and is orally bioavailable in humans [146,147].”
Lautrup, S., Cao, S., Long, X., Liu, B. H. M., Escobar-Doncel, B., Ferrante, A., Frank, J., Schmauck‐Medina, T., Leung, G. H. D., Liang, K. X., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71680
Launay, J., & Vodovar, N. (2026) · iScience · doi:10.1016/j.isci.2026.117276
O-methylation of phenolic natural products: translational insights from resveratrol
Habtemariam, S. (2026) · Medicinal Chemistry Research · doi:10.1007/s00044-026-03614-6
Narrative review of intravenous NAD+ and NAD+ precursors in wellness and translational medicine
Alangari, A., Arif, J. M., Qureshah, F. A., & Alkhodairy, F. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1887175
Zhang, W. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1865556
“In models of neurodegeneration, NR has been reported to improve neuronal survival markers, cognitive performance, and synaptic function in experimental models of neurodegeneration; however, translation of these findings to humans remains uncertain (6, 27).”
InfluentialKhanal, L., Cernioglo, K., Smilowitz, J. T., German, J. B., Underwood, M. A., Kuhn-Riordon, K. M., & Cacho, N. T. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-118516
“12 13 17 Mothers of infants in the NICU are particularly vulnerable to decreased milk production and thus demonstrate the greatest potential for bene-fiting from a supplement aimed at improving milk quality and lactation efficacy.”
Jiang, S., Liao, B., 王桂平, Sheng, R., Han, C., Jiang, Z., Pan, S., Wu, C., Liang, G., Zhu, Y., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06257-1
“* P < 0.05 vs. CON group; # P < 0.05, ## P < 0.01 vs. OGD/R group, as determined by one-way ANOVA followed by Tukey’s multiple comparison test dosing periods of weeks to months and consistently demonstrate biochemical target engagement [62].”
InfluentialBindingDB (2023) · UC San Diego · doi:10.7270/q2d50s11
Metadata
- Authors
- Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C.
- Affiliations
- University of Iowa (US)
- Queen's University Belfast (GB)
- ChromaDex (United States) (US)
- Corresponding author
- Brenner, Charles
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-10
- Volume
- 7
- Issue
- 1
- Pages
- 12948-12948
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5062546
- OpenAlex
- W2530388030
- Cited by
- 697
- References
- 57
- Citations by year
- 2026: 73 · 2025: 72 · 2024: 63 · 2023: 73 · 2022: 80 · 2021: 89 · 2020: 73 · 2019: 70 · 2018: 58 · 2017: 40 · 2016: 2
- FWCI
- 32.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
- Funders
- Roy J. Carver Charitable Trust
- National Institutes of Health
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/N001842/1)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Heart, Lung, and Blood Institute (R01HL108379)
- National Institute of General Medical Sciences (T32GM008629)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- nicotinamide riboside, NAD+ metabolism, oral bioavailability, pharmacokinetics, nicotinic acid, nicotinamide, dose-dependent effects
- MeSH terms
- Administration, Oral, Animals, Biological Availability, Humans, Leukocytes, Mononuclear, Liver, Male, Mice, Inbred C57BL, Middle Aged, NAD, Niacinamide, Pyridinium Compounds, Vitamins, Biomarkers, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.